6-Bromoflavone, obtained by bromination of flavanone, binds to central benzodiazepine receptors witb a Ki =70 nM and has a clear anxiolytic activity in mice, at 0.5 mgJkg, i.p. A survey of tbe structure/affinity relationship for tbose receptors in a series of natural and syntbetic flavonoids is presented.
MATERIALS ANO METHOOS
Flavanone was obtained from Extrasyntbese. Genay, France. Melting points are uncorrected. EIMS were measured in a Shimadzu QP-lOOO quadrupole mass spectrometer. NMR spectra were recorded in a Bruker AMX 400 spectrometer. UV spectra were determined in a Shimadzu UV -160A recording spectrophotometer. Adsorption chromatography was performed in columns (2.5 cmx40 cm) of silica gel, I ü-40 /L. type H (Sigma, USA), eluted stepwise with 200 mi of toluene, followed by equal volumes of toluene containing 1, 2, 3, 4 and 5% acetone (v/v). HPLC fractionations were performed using CI8 reversed phase Vydac columns (The Separation Group, Hesperia, CAL, USA). Elutions were carried out with a lineal gradient of 30 to 80% ACN in water, in 45 min, at a flow rate of 5 mL/min. The following flavonoids were kindly provided by Or. A. Pomilio: 9, 11, 12, 13, 14, 18, 19 and 20.
The synthesis of the brominated flavones was performed as follows: to a solution of flavanone (2.7 mmol) and pyridine (0.15 mmol) in CCI4 (9.6 mi), at O°C, a solution of bromine (6.2 nmol) in CCI4 (3.72 mi) was added dropwise. The mixture was stirred for I h at 30°C followed by 45 mino at 65°C. After cooling, tbe reaction mixture was washed witb two 10 mL portions of a saturated aqueous solution of Na2S20S and tben witb water, dried over Na2S04 and concentrated to dryness in a rotary evaporator.
The crude product dissolved in toluene was chromatographed in a column of silica gel, as described before. These pools were purified by HPLC as described. AlI the material in the major peaks in the chromatograms was recovered by evaporation of the solvent, recrystalized from ethanol-water and used for identification and assay.
Binding assays to central BDZ-Rs. Extensively washed synaptosomal membranes obtained from bovine cerebral cortices were used (5). The binding of ¡JH]FNZ (81.8 Cilnmol; NEN) was carried out as described previously (6) .
Animals. Male Swiss mice from our breeding stock, weighing 28-35 g were used. The animals were placed in groups of 10 with free access to water and food and maintained on a 12 h/I2h day/night cycle.
Pharmacological tests. In all the tests the mice were injected i.p. with vehicle or a solution of the drugs, 15 min before the assay.
The following tests were used: spontaneous ambulatory activity counts in an Opto-Varimex apparatus to measure locomotor activity; the elevated plus maze to measure anxiolityc effects; the holeboard to assay for sedative behavior and the horizontal-wire to detect myorelaxation. All these tests have been described previously (3).
RESUL TS AND DISCUSSION
Non specific bromination of flavanone (1) yielded flavone (2) and four brominated flavones ( Fig.  1 ) These have been separated by silica gel chromatography and HPLC. NMR analysis permitted the identification of 3-bromoflavone (3), 6-bromoflavone (4) and 3,6-dibromoflavone (5). The HPLC retention times (in min) for these compounds and of an unidentified tri-brominated flavone derivative (6) are: 16.5 (2),20.0 (3), 23.7 (4),26.4 (5), 30.7 (6) .
Identification of the bromoderivatives was achieved on the basis of lH and l3C NMR l-dimensional experiments accompanied by COSY-45 eH-1H-coupling), HC-COBI-DEC eH-l3C direct 1-bond coupling), (7), and HMBC eH-l3C long-range, 2-and 3-bond coupling), 2-dimensional experiments (8) Tribrornoflavone (6) . EIMS M+ 460 and 462 (ClsHg02Br3)' The amount of 6 recovered was so small that identification was not feasible.· Within theset of brominated flavones only 4 showed high affinity for the BDZ-R ( Table 1) . As a consequence 4 was further examined biochemically and for pharmacological activity.
Saturation curves of eH]FNZ revealed that 4 is a competitive ligand for the BDZ-Rs (Fig. 2 The behavior of 4 in the pharmacological tests was as follows: -it did not alter the spontaneous ambulatory locomotor activity of mice injected with doses up to 3 mglkg, i.p. (data analyzed by Newman-Keuls after ANOV A); -a significant anxiolytic activity was detected on the elevated plus maze in mice injected with 0.5 mglKg; i.p., as shown in Fig. 3 ; -in the holeboard test the results in Fig. 4 are indicative of sedative properties at 3 mglkg, i.p.; -the decrease in the percentage of animals grasping the horizontal wire was significant only at doses of 10 mglkg, (p<O.OOOl), (X2 test). Based on the abovementioned biochemical and pharmacological characterizations, we can conelude that 4 recognizes central BDZ-Rs specifically and in a competitive manner with a Ki of 70 nM and possesses anxiolytic properties at doses quite similar to those observed previously with diazepam (2). However, the anxiolytic action of 4 at doses less than 1 mglkg is not "contaminated" with sedative effects. The present findings indicate that 4 behaves as a full agonist of the central BDZ-Rs.
The affinities for the BDZ-Rs of flavanone and a range of natural and synthetic derivatives of flavone are now available and have been collected in Table 1 .
Flavone itself (2) shows a significant affinity (Ki = l¡.t.M) but the introduction of a bromine atom at C6 (4) raises this parameter 14 times, as already described, while bromination at C3 sharply decreases the affinity of the parent compound (3, 5) .
Hydroxyl groups at C5 and C7 (7) of flavone for central BDZ-Rs. Hydroxylation at C3 (9, 10, (12) (13) (14) , however, appears to be associated with much reduced affinity, and the same seems to be true for the presence of a catechol group at C3' and C4' (11) (12) (13) 15) . The effect of hydroxylation a C2' (14) is not sufficiently clear at this time. O-Methylation of hydroxil groups at CS, C7 or C4' (16, 18, 19-21) appears to be generally unfavorable. Introduction of a methoxyl group at C6 (15, 21, 22) does not seem to affect the affinity of the parent apigenin (8) or its 7-0-methyl ether derivative (21) to any great extent, and the same is true for bromination or iodination of chrysin (7) bromination of unsubstituted flavone at C6 (4). On the other hand, a chlorine or fluorine atom at C2' (25, 26) seems to reduce affinity somewhat. However, the addition of nitro groups at positions 6 and 3' of the flavone nucleus (27) induces a striking increase in affinity.
With respect to the pharmacological properties of these compounds the following correlations were detected: -in general, a very low affinity for the BDZ-R is associated with no anxiolytic activity as found with 10 and 15; -compounds 7 (1, 2), 8 (3) and 23 exhibited medium-low affinity for the BDZ-Rs, and had moderate anxiolytic properties with partial agonists behavior; -when the affinity reaches high levels, as shown in Table 1 for 4 and 27 (15) , the compounds behave either as full or partial agonists, respectively. Haberlein et al (13) have published a quantum chemical and spectroscopic approach to the study of structure-activity relationships in this class of compounds. Their conclusions are based on a small group of inactive flavanones plus two flavone derivatives with very low affinity for the BDZ-Rs and two flavones claimed to have low to medium affinity, One of these latter compounds, 5,7 dimethoxyflavone, should be identical to 16 in Table 1 of the present work. The structure of 16 is supported by our NMR data (14) . Unfortunately 16 is inactive in our assays (see Table 1 ). Until this discrepancy can be clarified we think that the conclusions of Haberlein et al (13) should be considered preliminary.
In conclusion, the present results strongly support our hypothesis that natural aml/or synthetic flavonoids represent a new family of BDZ-Rs ligands with interesting pharmacological profiles.
